Cart
sales@molnova.com
CeMMEC13
CAS No. 1790895-25-8
CeMMEC13 ( CeMMEC 13 )
Catalog No. M12696 CAS No. 1790895-25-8
A selective TAF1 second bromodomain inhibitor with IC50 of 2.1 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 230 | In Stock |
|
| 50MG | 417 | In Stock |
|
| 100MG | 614 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCeMMEC13
-
NoteResearch use only, not for human use.
-
Brief DescriptionA selective TAF1 second bromodomain inhibitor with IC50 of 2.1 uM.
-
DescriptionA selective TAF1 second bromodomain inhibitor with IC50 of 2.1 uM; shows high selectivity for the TAF1 (2) bromodomain over BRD4 (1), BRD9, CREBBP, EP300 and TAF1 (2) bromodomains (IC50>10 uM); synergizes with (+)-JQ1 to inhibit the proliferation of THP-1 and H23 lung adenocarcinoma cells.
-
SynonymsCeMMEC 13
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorTAF1
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1790895-25-8
-
Formula Weight336.30
-
Molecular FormulaC19H16N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 62 mg/mL (184.3 mM); Ethanol: 6 mg/mL (17.83 mM); Water: <1 mg/mL （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(C1=CC(N(C)C2=C1C=CC=C2)=O)NC3=CC=C(OCCO4)C4=C3
-
Chemical NameN-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,2-dihydro-1-methyl-2-oxo-4-quinolinecarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sdelci S, et al. Nat Chem Biol. 2016 Jul;12(7):504-10.
molnova catalog
related products
-
GW 841819X
GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain.
-
BI 7189
BI 7189 is a highly selective bromodomains of BRD9 and BRD7 inhibitor with IC50<50 nM for BRD9.
-
JQ1
(+)-JQ-1 (JQ1) is a potent, selective, cell-permeable BET bromodomain inhibitor with IC50 of 77 nM/33 nM for BRD4 BD1 and BD2, respectively.
